Related by context. All words. (Click for frequent words.) 65 β blockers 64 aldosterone antagonists 63 clomipramine 62 nicardipine 61 paricalcitol 61 lipid lowering agents 61 LV dysfunction 61 atherosclerotic renal artery stenosis 60 NSTE ACS 60 colorectal adenoma 60 venlafaxine Effexor 60 diabetic polyneuropathy 60 HbA 1c levels 60 cranial irradiation 60 oral anticoagulant therapy 59 hemoglobin A1c levels 59 citalopram Celexa 59 aldosterone antagonist 59 paroxetine Paxil 59 nonpharmacologic 59 thiazide diuretics 59 pyridostigmine 59 epidural steroid injection 59 dose atorvastatin 59 conventional angiography 59 NNT = 59 ATACAND 59 BENICAR HCT 59 intact parathyroid hormone 59 adenoma recurrence 59 methotrexate monotherapy 59 CYP#D# inhibitor 59 stratifying patients 59 postoperative complication 58 RISPERDAL ® 58 prognostic indicators 58 periprocedural 58 periprocedural MI 58 salmeterol fluticasone 58 glomerular filtration 58 platelet reactivity 58 glycoprotein IIb IIIa inhibitors 58 carotid endarterectomy CEA 58 aromatase inhibitors AIs 58 APTIVUS r 58 liposomal amphotericin B 58 lipid lowering drugs 58 dose statin therapy 58 cilostazol 58 antibiotic prophylaxis 58 risperidone Risperdal 58 glycated hemoglobin levels 58 Perforomist Inhalation Solution 58 perioperatively 58 sertraline Zoloft 58 plasma homocysteine 58 timolol maleate 58 endothelin antagonists 57 biologic DMARDs 57 sulphonylureas 57 carotid artery stenting CAS 57 serum urate levels 57 Teriflunomide 57 postoperative chemotherapy 57 randomized controlled trials RCTs 57 divalproex sodium 57 pretest probability 57 lipid abnormalities 57 postoperative AF 57 K ras mutations 57 lipid parameters 57 clinically meaningful reductions 57 prazosin 57 subthreshold depression 57 morphometric vertebral fractures 57 desvenlafaxine succinate 57 beta carotene supplementation 57 thromboembolic disease 57 prodromal symptoms 57 MoxDuo TM IR 57 QVAR R 57 posttransplant 57 QIDS SR 57 CaPre TM 57 N acetylcysteine 57 thromboembolic complications 57 donepezil Aricept 57 reuptake inhibitor 57 labetalol 57 multivariable adjusted 57 thromboprophylaxis 57 gastrointestinal GI bleeding 57 oral antidiabetes drugs 57 selenium supplementation 57 Subgroup analyzes 57 mitochondrial toxicity 56 renal scarring 56 antiangiogenic therapy 56 parkinsonian symptoms 56 diabetes mellitus DM 56 solifenacin 56 symptomatic VTE 56 patients undergoing CABG 56 ACCOMPLISH 56 BEXXAR Therapeutic Regimen 56 macrovascular events 56 bi ventricular pacing 56 Intervention Effectiveness 56 postoperative mortality 56 Combination therapy 56 VTE prophylaxis 56 carotid stenosis 56 hematological parameters 56 postprandial hyperglycemia 56 hyperalgesia 56 Symptom severity 56 postoperative delirium 56 debulking surgery 56 agomelatine 56 oral anticoagulation 56 intracerebral haemorrhage 56 nonoperative 56 pharmacologic therapy 56 inhaled nitric oxide 56 intracranial stenosis 56 extrapyramidal symptoms 56 viral kinetics 56 echocardiographic parameters 56 percutaneous vertebroplasty 56 VADT 56 Subgroup analysis 56 acamprosate 56 antiplatelet drugs 56 glycemic variability 56 hemorrhagic complications 56 Valdoxan 56 ADAS Cog 56 unresectable tumors 56 PRADAXA 56 thoracoscopic lobectomy 56 probiotic supplementation 56 milrinone 56 chronic LBP 56 hypofractionated radiation 56 HBeAg negative patients 56 STRIDE PD 56 subgroup analyzes 56 pharmacological intervention 56 dyslipidaemia 56 antithrombotic therapy 56 Y BOCS 56 nonoperative treatment 56 liver metastasis 55 perioperative complications 55 Pharmacokinetic studies 55 BENICAR 55 CYPHER R Sirolimus eluting 55 cardioprotective effects 55 p = .# [002] 55 antiplatelet therapies 55 antioxidant supplementation 55 acromegalic patients 55 primary aldosteronism 55 alpha blocker 55 non pharmacological interventions 55 MEVACOR 55 efavirenz EFV 55 Plasma concentrations 55 platelet inhibition 55 INVEGA ® 55 somatostatin analog 55 hepatic fibrosis 55 reboxetine 55 Coronary artery bypass grafting 55 Venlafaxine 55 ziconotide 55 paroxetine sertraline 55 somatostatin analogs 55 postoperative atrial fibrillation 55 MBCT 55 logistic regression analysis 55 atypical antipsychotic medications 55 elevated troponin 55 adenoma detection 55 fibrate drugs 55 STEP BD 55 comorbid depression 55 triacylglycerol concentrations 55 silent myocardial ischemia 55 tacrolimus ointment 55 conditional logistic regression 55 Observational studies 55 FDG-PET/CT 55 DAPT 55 EFFEXOR XR 55 menstrual migraine 55 neuroleptic 55 depressive symptom 55 HF ACTION 55 tipranavir r 55 Logistic regression 55 nonpharmacological 55 nonfasting triglyceride levels 55 CIPN 55 HIV HCV coinfected 55 haematologic 55 acute mania 55 Coronary Artery Bypass Graft 54 CIMZIA ™ 54 ABVD 54 pCR 54 liver histology 54 antidepressant efficacy 54 oncologic outcomes 54 aromatase inhibitor therapy 54 dietary modification 54 argatroban 54 prescribed antipsychotic medication 54 coronary CTA 54 DHEA supplementation 54 prostate cancer CaP 54 revascularization procedures 54 cerebral oxygenation 54 Pharmacologic 54 recurrent venous thromboembolism 54 pharmacogenetic testing 54 tapentadol ER 54 electro acupuncture 54 Suicidal ideation 54 coronary stenoses 54 liver resection 54 nonadherence 54 meta analytic 54 angiographically 54 pharmacologic treatments 54 coinfected patients 54 recurrent miscarriage 54 Elitek 54 A1c levels 54 syncopal episodes 54 systolic hypertension 54 everolimus eluting stents 54 Zevalin consolidation 54 Meta analyzes 54 Randomized clinical trials 54 lipid lowering therapy 54 Multiple logistic regression 54 lenalidomide dexamethasone 54 baseline HbA1c 54 postoperative pulmonary 54 riociguat 54 tryptophan depletion 54 MitraClip device 54 placebo controlled clinical 54 perimenopausal women 54 Generalized Anxiety Disorder 54 Univariate analysis 54 pharmacological therapies 54 serum estradiol 54 postoperative morbidity 54 voiding dysfunction 54 rimonabant #mg 54 ACTEMRA TM 54 pulmonary artery banding 54 T1DM 54 neuroleptics 54 antiphospholipid antibodies 54 histological subtype 54 SSRI citalopram 54 certolizumab 54 stellate ganglion block 54 glycosylated hemoglobin levels 54 heparin induced thrombocytopenia 54 resynchronization therapy 54 TriRima 54 Adjunctive 54 Preoperatively 54 HbA1c levels 54 inflammatory biomarkers 54 hypochondriasis 54 Selective serotonin reuptake inhibitors 54 warfarin sodium 54 MDRD 54 cardioprotection 54 CONCERTA ® 54 Cardiotoxicity 54 exploratory endpoints 54 KAPIDEX 54 tapentadol IR 54 KRAS status 54 intranasal corticosteroids 54 cytoreductive surgery 54 episodic migraine 54 eosinophil count 54 renal artery stenosis 54 sirolimus eluting stents 54 ER CHOP 54 Afib 54 pre operatively 54 oncological outcomes 54 AGILECT ® 54 Bergenstal 54 periprosthetic infection 54 perioperative morbidity 54 prolactin elevation 54 logistic regression analyzes 54 BARI 2D 54 EXJADE 54 leukotriene receptor antagonist 54 renal tumors 53 meta regression 53 BPH LUTS 53 postsurgical 53 guideline concordant 53 pharmacotherapies 53 fluoxetine Prozac 53 thrombotic complications 53 functional dyspepsia 53 nomograms 53 myocardial viability 53 thrombus aspiration 53 Akathisia 53 β blocker 53 fibromyalgia syndrome 53 CsA 53 prospective observational studies 53 SYNTAX 53 hsCRP levels 53 graft occlusion 53 pulmonary toxicity 53 clopidogrel Plavix 53 CLBP 53 SYNTAX trial 53 LTRA 53 Paroxetine 53 Kaplan Meier analysis 53 Atomoxetine 53 preoperatively 53 NSTEMI 53 adjuvant therapies 53 Randomized trials 53 stone formers 53 sustained virological response 53 paclitaxel eluting stents 53 montelukast 53 antireflux surgery 53 postoperative infections 53 guanfacine 53 treated nonsurgically 53 elevated CRP 53 Bupropion 53 anthropometric measures 53 comorbid disorders 53 gastroesophageal reflux GERD 53 valsartan Diovan 53 bivariate analyzes 53 Vascugel ® 53 developmental neurotoxicity 53 pemetrexed Alimta 53 BPS IC 53 hepatic lesions 53 electrophysiologic 53 Stent thrombosis 53 elevated serum creatinine 53 osteopathic manipulative treatment 53 mGluR5 inhibitors 53 noncardiovascular mortality 53 NIHSS score 53 secondary efficacy endpoint 53 ADCS CGIC 53 percutaneous cryoablation 53 glatiramer acetate 53 Multivariate logistic regression 53 CT angiograms 53 EDEMA3 trial 53 somatoform disorders 53 embolic stroke 53 LAGB 53 dual antiplatelet 53 colonoscopic 53 osteoporotic compression fractures 53 nephron sparing surgery 53 prospectively stratified 53 macrovascular disease 53 Lipoic acid 53 serum lipid 53 Randomized controlled 53 malabsorptive 53 abnormal glucose tolerance 53 creatine supplementation 53 beta blocker therapy 53 angiographic outcomes 53 tumor histology 53 LUTS 53 Frobell 53 lipid lowering medications 53 RRMS patients 53 Lucentis monotherapy 53 clinicopathological 53 IBS sufferers 53 carotid artery stenosis 53 perioperative mortality 53 colorectal neoplasia 53 elevated triglyceride levels 53 affective psychosis 53 SSRI SNRI 53 intrathecal baclofen 53 cardiac autonomic 53 RE LY 53 corrected QT interval 53 biochemical abnormalities 53 bacterial prostatitis 53 lipoprotein profiles 53 urothelial cancer 53 clinically meaningful improvements 53 Mechanistic studies 53 Serum concentrations 53 virological response 53 intravascular hemolysis 52 tocilizumab 52 decompensated cirrhosis 52 univariate analyzes 52 doxorubicin docetaxel 52 Montgomery Åsberg Depression 52 graft patency 52 euthymic patients 52 Logistic regression analysis 52 preoperative chemotherapy 52 metabolic parameters 52 atypical neuroleptics 52 androgen suppression 52 rEEG 52 analgesic efficacy 52 allergic airway inflammation 52 dietary interventions 52 serum retinol 52 hypogonadotropic hypogonadism 52 serum uric acid 52 carotid IMT 52 prospective multicentre 52 DVT PE 52 adjuvant radiation 52 ALI ARDS 52 treat benign prostatic 52 HbA1C levels 52 symptomatic carotid stenosis 52 sertraline 52 alteplase 52 genetic polymorphisms 52 dietary carbohydrate 52 Cognitive behavioral 52 Abilify aripiprazole 52 radiographic outcomes 52 Lamotrigine 52 TMS Therapy 52 triglyceride concentrations 52 physiologic responses 52 cardiovascular calcification 52 testosterone supplementation 52 adjuvant tamoxifen 52 GG genotype 52 CT perfusion 52 hyperhomocysteinemia 52 intima media thickness 52 symptom checklist 52 neurodevelopmental outcome 52 anticholinergic medication 52 treating neuropathic pain 52 Stop Hypertension DASH diet 52 Radical prostatectomy 52 SERCA2a 52 SAMe 52 anticholinergics 52 atherogenic dyslipidemia 52 Lactobacillus KW 52 tHcy 52 PROactive study 52 weekly subcutaneous injections 52 Renal Cell Carcinoma RCC 52 diagnosing ADHD 52 etiologic 52 ischemic cardiomyopathy 52 psychodynamic psychotherapy 52 serum BDNF 52 pramipexole 52 tenecteplase 52 carotid angioplasty 52 catheter ablations 52 NSABP B 52 Cardiorespiratory fitness 52 Acute Coronary Syndromes ACS 52 Cochrane Systematic Review 52 tipranavir 52 poststroke 52 experimentally induced 52 CALERIE 52 oxysterols 52 clinico pathological 52 peginterferon alpha 52 prognostic variables 52 metabolic disturbances 52 transurethral 52 RCTs 52 plasma triglycerides 52 interrater reliability 52 Ranibizumab 52 Ziprasidone 52 esophagogastric 52 venous thromboembolic disease 52 Multivariate analysis 52 darunavir ritonavir 52 antiandrogens 52 coronary calcification 52 nonsurgical treatment 52 quetiapine 52 clopidogrel pretreatment 52 elevated triglycerides 52 Cognitive behavioral therapy 52 Elevated serum 52 Garcia Manero 52 CPAP adherence 51 ICD therapy 51 multivariate analyzes 51 perfusion defects 51 chronic myocardial ischemia 51 glucose lowering 51 PANSS scores 51 anticoagulation therapy 51 pharmacological interventions 51 chemoembolization 51 HORIZONS AMI trial 51 cerebral microbleeds 51 mITT population 51 histologically proven 51 impair fertility 51 Poisson regression 51 enhanced external counterpulsation 51 serum lipids 51 cardiometabolic risk 51 serum lipid levels 51 prospective longitudinal 51 anxiolytic 51 varenicline Chantix 51 type2 diabetes 51 chronic constipation CC 51 levodopa induced 51 EGFR mutation status 51 receptor antagonism 51 chlamydial infection 51 Oncotype DX Recurrence Score 51 adenotonsillectomy 51 adjuvant systemic 51 nonarteritic anterior ischemic optic 51 umol L 51 receptor subtypes 51 pharmacoeconomic 51 prospective multicenter study 51 highly emetogenic chemotherapy 51 neurocognitive function 51 DLQI 51 chemoprevention trials 51 CVD mortality 51 ACCORD Lipid 51 neurocognitive deficits 51 colorectal neoplasms 51 tolterodine 51 colorectal carcinoma 51 cardiovascular morbidity 51 antiphospholipid syndrome 51 SLNB 51 surgical debulking 51 sacral nerve stimulation 51 spinal manipulative 51 NNRTI resistance 51 ABCB1 51 spinal metastases 51 AMBIEN CR 51 warfarin dosage 51 antibiotic regimens 51 psychostimulants 51 transcranial Doppler ultrasound 51 Cypher Stent 51 underlying pathophysiology 51 MMSE scores 51 Mindfulness Based Cognitive Therapy 51 antidepressive 51 cortical stimulation 51 aminotransferases 51 clinically meaningful improvement 51 interobserver 51 pharmacodynamic parameters 51 metreleptin 51 plasma lipids 51 spirometric 51 GABRA2 51 DSM IV diagnoses 51 aripiprazole 51 hemodynamic variables 51 subsyndromal 51 Depressive symptoms 51 Coronary artery bypass graft 51 neurodevelopmental outcomes 51 PsA 51 oral triptans 51 Valproic acid 51 antitrypsin 51 GBA mutations 51 carotid plaque 51 ConclusionThis 51 E. faecalis 51 convenient dosing regimen 51 pharmacological therapy 51 IBS C 51 secondary efficacy endpoints 51 Computed tomography 51 TOPAMAX ® 51 comorbid conditions 51 bronchopulmonary dysplasia BPD 51 glycemic diet 51 varespladib 51 albumin excretion 51 inorganic nitrate 51 preoperative diagnosis 51 guanfacine extended release 51 idiopathic Parkinson disease 51 NeuroStar TMS Therapy 51 perfusion abnormalities 51 chronic prostatitis chronic 51 ICD implantation 51 coronary revascularization 51 hepatic fat 51 therapeutic regimens 51 waist circumference WC 51 HBeAg + 51 urodynamic parameters 51 UKPDS 51 pathogenetic mechanisms 51 colorectal polyp 51 multivariate regression analysis 51 nonfatal MI 51 pharmacological approaches 50 prespecified secondary 50 plasma lipid 50 neurophysiologic 50 fat vegan diet 50 chromium picolinate supplementation 50 leptin deficient mice 50 Achilles tendon ruptures 50 glycemia 50 FLOMAX 50 psychiatric comorbidity 50 postdischarge 50 ILLUSTRATE 50 Hematologic toxicity 50 CHADS 50 titration regimen 50 PHQ 9 50 tertile 50 APOE genotype 50 Relora 50 neuroprotective effects 50 QTc intervals 50 antiepileptic medications 50 RE LY ® 50 daytime alertness 50 dyspareunia 50 psychiatric comorbidities 50 buproprion 50 urate levels 50 receptor inhibitor 50 pharmacologic intervention 50 tryptase 50 neoadjuvant 50 NMDA antagonist 50 MTWA testing 50 GP IIb IIIa inhibitor 50 neurocognitive outcomes 50 RhuDex 50 fludarabine cyclophosphamide 50 actigraphy 50 asthma exacerbation 50 perfusion CT 50 iNO 50 SOD2 gene 50 chemoradiotherapy 50 medication nonadherence 50 somatic symptoms 50 EECP therapy 50 calcium supplementation 50 Brief Psychiatric 50 postmenopausal hormone therapy 50 serotonin norepinephrine 50 carotid atherosclerosis 50 microvascular complications 50 Natalizumab 50 psychopharmacological 50 OncotypeDX 50 carotid artery narrowing 50 postoperative radiotherapy 50 Telintra 50 adjunctive ABILIFY 50 serum biomarkers 50 chemosensitivity 50 non squamous histology 50 comorbid anxiety 50 subtrochanteric 50 haemodynamic 50 PegIFN RBV 50 Elevated triglycerides 50 prognostic markers 50 cerebrovascular events 50 serum PTH 50 operable breast cancer 50 Histalean 50 biologic DMARD 50 Primary endpoints 50 antitumor efficacy 50 warfarin dosing 50 MDRD equation 50 TAXUS VI 50 adiponectin levels 50 pregabalin 50 imipramine 50 pulmonary hypertension PH 50 catheter angiography 50 serum vitamin D 50 CARE HF 50 albuminuria 50 chronic periodontitis 50 ADAS cog 50 Epidemiologic studies 50 conjugated equine estrogens 50 HDL2 50 hypertension diabetes mellitus 50 cognitive behavioral therapies 50 CYPHER ® 50 oral prednisolone 50 APOE e4 50 paclitaxel Taxol R 50 nulliparous women 50 functional mitral regurgitation 50 postoperative complications 50 refractory angina 50 sleeve lobectomy 50 nonpregnant women 50 serum homocysteine 50 subclinical atherosclerosis 50 cystinosis patients 50 autonomic dysfunction 50 SGRQ 50 risk stratification 50 p# activation 50 Cochrane reviewers 50 efficacious therapies 50 BMC Musculoskeletal Disorders 50 pulmonary dysfunction 50 ropinirole 50 serotonin reuptake inhibition 50 opioid dependent 50 nodal metastases 50 atherothrombotic 50 sternal wound infections 50 salivary cortisol 50 virologic response 50 undergoing coronary angiography 50 Leydig cell 50 CONCERTA 50 Non inferiority 50 pharmacokinetic interaction 50 fetal malformations 50 sildenafil Viagra 50 cerebral perfusion 50 CINQUIL 50 electroacupuncture 50 baclofen 50 metabolite concentrations 50 untreated OSA 50 tumor subtype 50 Main Outcome Measure 50 Plain radiographs 50 multicenter trials 49 serotonin reuptake inhibitor 49 PNES 49 Focalin XR 49 spinal manipulation 49 subscore 49 Zemplar Capsules 49 immunoconjugate 49 carotid revascularization 49 serotonin reuptake inhibitors 49 -#.# ± [002] 49 Dr. Cliby 49 somatic complaints 49 cholinesterase inhibitors 49 lipid profiles 49 HRQL 49 nocturnal hypoglycaemia 49 clinical pharmacology studies 49 pancreatic prostate 49 hemostatic efficacy 49 antidepressant escitalopram 49 radiographic findings 49 NeuroVax 49 differential gene expression 49 sonographic diagnosis 49 Boden Albala 49 venlafaxine 49 HRQOL 49 plasma kallikrein 49 metabolic alterations 49 lung resection 49 inflammatory polyarthritis 49 endovascular interventions 49 CAM therapies 49 CORE OM 49 enkephalin 49 predictive validity 49 potentially modifiable 49 subclinical hyperthyroidism 49 therapy CBT 49 extracolonic findings 49 Lu AA# 49 progestogens 49 pulmonary capillary wedge 49 confidence interval CI 49 Aripiprazole 49 airway hyperresponsiveness 49 psychodynamic therapy 49 non affective psychosis 49 OnDose TM 49 escitalopram 49 vitro experiments 49 dietary nitrate 49 SIMPADICO 49 R0 resection 49 N telopeptide 49 vesicoureteral reflux 49 anti androgen 49 WBPA 49 nonmetastatic prostate cancer 49 PSQI 49 digoxin toxicity 49 Escitalopram 49 pathophysiological mechanisms 49 Soy isoflavones 49 symptomatic hyponatremia 49 MTHFD1L gene 49 LRP5 49 chorioamnionitis 49 shorter telomere length 49 NLX P# 49 tissue oxygenation 49 plasma adiponectin 49 familial aggregation 49 uncontrolled asthma 49 nortriptyline 49 virologic suppression 49 poststroke depression 49 CRT ICD 49 Overactive Bladder OAB 49 OAB symptoms 49 SIBO 49 KRAS mutation status 49 #q# deletion 49 Sjögren syndrome 49 Comorbidity 49 Multivariate analyzes 49 coronary interventions 49 Singh Manoux 49 anterior temporal 49 mGluR5 antagonist 49 serum IgE 49 VESIcare 49 incomplete revascularization 49 ejaculatory function 49 Transcranial Magnetic Stimulation TMS 49 serum concentrations 49 immunomodulation 49 metabolic dysfunction 49 adiponectin concentrations 49 GPi 49 MetS 49 EBV infection 49 confounder 49 intravenous tissue plasminogen 49 interindividual variability 49 Likert scale 49 elevated fasting glucose 49 Uroxatral 49 intravesical chemotherapy 49 Aggressive Drug Evaluation 49 Comorbidities 49 Edinburgh Postnatal Depression 49 buprenorphine naloxone 49 reflux symptoms 49 ob ob mice 49 viral titers 49 tumor recurrence 49 CIMZIA R 49 DPNP 49 neuroimaging studies 49 FFR guided 49 fasting glucose levels 49 Schema Therapy 49 Cardiopulmonary bypass 49 elevated homocysteine 49 peginterferon 49 myocardial reperfusion 49 psychopharmacologic 49 behavioral interventions 49 Cognitive impairment 49 Multiple linear regression 49 ABSORB trial 49 ventricular tachyarrhythmia 49 choroidal vasculopathy 49 intraoperative complications 49 urinary incontinence UI 49 subscale scores 49 c reactive protein 49 Cystic Fibrosis Questionnaire Revised 49 dosimetric 49 androgen deprivation 49 rheumatoid factor 49 Uprima 49 epidural analgesia 49 lactate dehydrogenase 49 ULTRAM ® 49 hyperbilirubinemia 49 atherosclerotic progression 49 KIF6 carriers 48 Post operatively 48 erection hardness 48 plasma homocysteine levels 48 anti TNFs 48 psychoeducation 48 psychotherapeutic interventions 48 relapsing multiple sclerosis 48 fetal chromosomal 48 antiplatelet therapy 48 ASCUS 48 dysmenorrhea 48 citalopram 48 CYP#C# genotype 48 PSADT 48 myocardial function 48 dietary glycemic index 48 HIF PHIs 48 distal colon cancer 48 desvenlafaxine 48 Shlipak 48 symptomatic intracerebral hemorrhage 48 HLA DRB1 48 serotonin synthesis 48 multiple linear regression 48 phenelzine 48 impaired insulin secretion 48 acute postoperative 48 BMI z 48 cardiotoxic effects 48 Endothelial function 48 Dual Antiplatelet Therapy 48 protein excretion 48 Bicillin LA 48 sustained virologic response 48 vascular endothelial dysfunction 48 QVAR ® 48 lupus anticoagulant 48 colorectal adenomas 48 hematologic malignancy 48 pharmacokinetic characteristics 48 logistic regression models 48 HDRS 48 untreated hypothyroidism 48 sustained ventricular tachycardia 48 ß carotene 48 tumor resection 48 cholinesterase inhibitor 48 rs# [002] 48 syndromal 48 depressive symptomatology 48 Pain Rating Scale 48 oral naltrexone 48 Relapsing remitting 48 glial tumors 48 improves insulin sensitivity 48 sociodemographic characteristics 48 duloxetine Cymbalta 48 prelicensure 48 stepwise logistic regression 48 Immunohistochemical analysis 48 HDL cholesterol triglycerides 48 interpersonal psychotherapy 48 Vectibix monotherapy 48 NasalFent 48 PREVACID 48 UDCA 48 relieving menopausal symptoms 48 attention-deficit/hyperactivity disorder ADHD 48 gallstone disease